Better Therapeutics, Inc. (BTTX) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. SPY
8. XYZ
9. ANET
10. CVS

Go back to Better Therapeutics, Inc. (BTTX) Tops Q2 EPS by 3c

Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 11, 2022 7:30 AM EDT

Completed pivotal trial of BT-001 for type 2 diabetes and reported positive secondary endpoint results after 180 days of treatment

On track to submit de novo classification request for BT-001 with FDA in third quarter of 2022

Completed enrollment in LivVita Liver Study for nonalcoholic fatty liver disease

Appointed Frank Karbe as President and Chief Executive Officer and member of Board of Directors

Company to host conference call and webcast today at 8:30 a.m. ET

SAN FRANCISCO--(BUSINESS... More